H. Pylori

Clinical Trial Info

  • Category

    Featured Trials, H. Pylori

Helicobacter pylori (H. pylori) is a type of bacteria.

Many researchers believe that H. pylori is responsible for the majority of peptic ulcers, chronic gastritis and increases the risk of developing gastric cancer.

Symptoms of H. pylori may include gnawing or burning pain, nausea, vomiting, or loss of appetite.
ClinicalTrials.gov Study Details
Helicobacter Pylori Infection
A Phase 3 Randomized Multicenter Study to Evaluate the Efficacy and Safety of Open-Label Dual Therapy with Oral Vonoprazan 20 mg or Double-Blind Triple Therapy with Oral Vonoprazan 20 mg Compared to Double-Blind Triple Therapy with Oral Lansoprazole 30 mg Daily in Patients with Helicobacter Pylori Infection

Photo of Bharat K Misra M.D.
Gastroenterologist and Research Director Encore Borland Groover Clinical Research
4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.

Contact Research